|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2.
|
Kobayashi H, Mochizuki H, Sugihara K, et
al: Characteristics of recurrence and surveillance tools after
curative resection for colorectal cancer: a multicenter study.
Surgery. 141:67–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Brabletz T, Hlubek F, Spaderna S, et al:
Invasion and metastasis in colorectal cancer:
epithelial-mesenchymal transition, mesenchymal-epithelial
transition, stem cells and beta-catenin. Cells Tissues Organs.
179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher’s conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009.PubMed/NCBI
|
|
7.
|
Spaderna S, Schmalhofer O, Hlubek F, et
al: A transient, EMT-linked loss of basement membranes indicates
metastasis and poor survival in colorectal cancer.
Gastroenterology. 131:830–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Eger A, Aigner K, Sonderegger S, et al:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ohira T, Gemmill RM, Ferguson K, et al:
WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U
S A. 100:10429–10434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chua HL, Bhat-Nakshatri P, Clare SE, et
al: NF-kappaB represses E-cadherin expression and enhances
epithelial to mesenchymal transit ion of mammary epithelial cells:
Potential involvement of ZEB-1 and ZEB-2. Oncogene. 26:711–724.
2007. View Article : Google Scholar
|
|
11.
|
Graham TR, Zhau HE, Odero-Marah VA, et al:
Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives
epithelial-to-mesenchymal transition in human prostate cancer
cells. Cancer Res. 68:2479–2488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Spaderna S, Schmalhofer O, Wahlbuhl M, et
al: The transcriptional repressor ZEB1 promotes metastasis and loss
of cell polarity in cancer. Cancer Res. 68:537–44. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sánchez-Tilló E, Lázaro A, Torrent R, et
al: ZEB1 represses E-cadherin and induces an EMT by recruiting the
SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 29:3490–3500.
2010.PubMed/NCBI
|
|
14.
|
Xiong H, Hong J, Du W, et al: Roles of
STAT3 and ZEB1 proteins in E-cadherin down-regulation and human
colorectal cancer epithelial-mesenchymal transition. J Biol Chem.
287:5819–5832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Waldmann J, Feldmann G, Slater EP, et al:
Expression of the zinc-finger transcription factor Snail in
adrenocortical carcinoma is associated with decreased survival. Br
J Cancer. 99:1900–1907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Iwatsuki M, Mimori K, Yokobori T, et al:
Epithelial-mesenchymal transition in cancer development and its
clinical significance. Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Drake JM, Strohbehn G, Bair TB, et al:
ZEB1 enhances transendothelial migration and represses the
epithelial phenotype of prostate cancer cells. Mol Biol Cell.
20:2207–2217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Takeyama Y, Sato M, Horio M, et al:
Knockdown of ZEB1, a master epithelial-to-mesenchymal transition
(EMT) gene, suppresses anchorage-independent cell growth of lung
cancer cells. Cancer Lett. 296:216–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Singh M, Spoelstra NS, Jean A, et al: ZEB1
expression in type I vs type II endometrial cancers: a marker of
aggressive disease. Mod Pathol. 21:912–923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Okugawa Y, Toiyama Y, Tanaka K, et al:
Clinical significance of zinc finger E-box binding homeobox 1
(ZEB1) in human gastric cancer. J Surg Oncol. 106:280–285. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhou YM, Cao L, Li B, et al:
Clinicopathological significance of ZEB1 protein in patients with
hepatocellular carcinoma. Ann Surg Oncol. 19:1700–1706. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Shen A, Zhang Y, Yang H, et al:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Stridh P, Thessen Hedreul M, Beyeen AD, et
al: Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1
as a candidate gene regulating experimental neuroinflammation in
rat. PLoS One. 5:e127162010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hidaka T, Nakahata S, Hatakeyama K, et al:
Down-regulation of TCF8 is involved in the leukemogenesis of adult
T-cell leukemia/lymphoma. Blood. 112:383–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Genetta T, Ruezinsky D and Kadesch T:
Displacement of an E-box-binding repressor by basic
helix-loop-helix proteins: Implications for B-cell specificity of
the immunoglobulin heavy-chain enhancer. Mol Cell Biol.
14:6153–6163. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Fontemaggi G, Gurtner A, Strano S, et al:
The transcriptional repressor ZEB regulates p73 expression at the
crossroad between proliferation and differentiation. Mol Cell Biol.
21:8461–8470. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Putzke AP, Ventura AP, Bailey AM, et al:
Metastatic progression of prostate cancer and e-cadherin regulation
by zeb1 and SRC family kinases. Am J Pathol. 179:400–410. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Argast GM, Krueger JS, Thomson S, et al:
Inducible expression of TGFbeta, Snail and Zeb1 recapitulates EMT
in vitro and in vivo in a NSCLC model. Clin Exp Metastasis.
28:593–614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Roy BC, Kohno T, Iwakawa R, et al:
Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of
human lung cancer cells. Lung Cancer. 70:136–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Kim T, Veronese A, Pichiorri F, et al: p53
regulates epithelialmesenchymal transition through microRNAs
targeting ZEB1 and ZEB2. J Exp Med. 208:875–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
